SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $44.90 million. The enterprise value is $56.23 million.
| Market Cap | 44.90M |
| Enterprise Value | 56.23M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.60 million shares outstanding. The number of shares has increased by 26.84% in one year.
| Current Share Class | 8.60M |
| Shares Outstanding | 8.60M |
| Shares Change (YoY) | +26.84% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 4.91% |
| Owned by Institutions (%) | 25.02% |
| Float | 6.19M |
Valuation Ratios
The trailing PE ratio is 6.68.
| PE Ratio | 6.68 |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| Forward PS | 1.48 |
| PB Ratio | 16.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.67 |
| P/OCF Ratio | 8.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.19, with an EV/FCF ratio of 13.36.
| EV / Earnings | 3.69 |
| EV / Sales | 1.28 |
| EV / EBITDA | 13.19 |
| EV / EBIT | 18.32 |
| EV / FCF | 13.36 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 7.43.
| Current Ratio | 1.28 |
| Quick Ratio | 0.84 |
| Debt / Equity | 7.43 |
| Debt / EBITDA | 4.66 |
| Debt / FCF | 4.92 |
| Interest Coverage | 0.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 5.51% |
| Return on Invested Capital (ROIC) | 22.32% |
| Return on Capital Employed (ROCE) | 16.65% |
| Weighted Average Cost of Capital (WACC) | 13.48% |
| Revenue Per Employee | $800,400 |
| Profits Per Employee | $277,436 |
| Employee Count | 55 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 1.61 |
Taxes
In the past 12 months, SANUWAVE Health has paid $92,000 in taxes.
| Income Tax | 92,000 |
| Effective Tax Rate | 0.60% |
Stock Price Statistics
The stock price has decreased by -83.51% in the last 52 weeks. The beta is 1.42, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -83.51% |
| 50-Day Moving Average | 4.80 |
| 200-Day Moving Average | 14.10 |
| Relative Strength Index (RSI) | 52.14 |
| Average Volume (20 Days) | 45,824 |
Short Selling Information
The latest short interest is 245,504, so 2.85% of the outstanding shares have been sold short.
| Short Interest | 245,504 |
| Short Previous Month | 240,323 |
| Short % of Shares Out | 2.85% |
| Short % of Float | 3.97% |
| Short Ratio (days to cover) | 4.33 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $44.02 million and earned $15.26 million in profits. Earnings per share was $0.78.
| Revenue | 44.02M |
| Gross Profit | 33.60M |
| Operating Income | 3.07M |
| Pretax Income | 15.35M |
| Net Income | 15.26M |
| EBITDA | 4.26M |
| EBIT | 3.07M |
| Earnings Per Share (EPS) | $0.78 |
Balance Sheet
The company has $9.38 million in cash and $20.71 million in debt, with a net cash position of -$11.33 million or -$1.32 per share.
| Cash & Cash Equivalents | 9.38M |
| Total Debt | 20.71M |
| Net Cash | -11.33M |
| Net Cash Per Share | -$1.32 |
| Equity (Book Value) | 2.79M |
| Book Value Per Share | 0.32 |
| Working Capital | 5.03M |
Cash Flow
In the last 12 months, operating cash flow was $5.22 million and capital expenditures -$1.01 million, giving a free cash flow of $4.21 million.
| Operating Cash Flow | 5.22M |
| Capital Expenditures | -1.01M |
| Depreciation & Amortization | 1.19M |
| Net Borrowing | -8.50M |
| Free Cash Flow | 4.21M |
| FCF Per Share | $0.49 |
Margins
Gross margin is 76.33%, with operating and profit margins of 6.97% and 34.66%.
| Gross Margin | 76.33% |
| Operating Margin | 6.97% |
| Pretax Margin | 34.87% |
| Profit Margin | 34.66% |
| EBITDA Margin | 9.68% |
| EBIT Margin | 6.97% |
| FCF Margin | 9.56% |
Dividends & Yields
SANUWAVE Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -26.84% |
| Shareholder Yield | -26.84% |
| Earnings Yield | 14.98% |
| FCF Yield | 9.37% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 18, 2024. It was a reverse split with a ratio of 1:375.
| Last Split Date | Oct 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:375 |
Scores
SANUWAVE Health has an Altman Z-Score of -3.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.54 |
| Piotroski F-Score | 4 |